Cargando…
Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells
Cancer-related deaths are approaching 10 million each year. Survival statistics for some cancers, such as ovarian cancer, have remained unchanged for decades, with women diagnosed at stage III or IV having over 80% chance of a lethal cancer recurrence after standard first-line treatment (reductive s...
Autores principales: | Moody, Rhiane, Wilson, Kirsty, Jaworowski, Anthony, Plebanski, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139800/ https://www.ncbi.nlm.nih.gov/pubmed/32183059 http://dx.doi.org/10.3390/cancers12030673 |
Ejemplares similares
-
Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity
por: Moody, Rhiane, et al.
Publicado: (2021) -
Adaptive Immunity and the Risk of Autoreactivity in COVID-19
por: Moody, Rhiane, et al.
Publicado: (2021) -
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy
por: Moody, Rhiane, et al.
Publicado: (2021) -
A Model to Study the Impact of Polymorphism Driven Liver-Stage Immune Evasion by Malaria Parasites, to Help Design Effective Cross-Reactive Vaccines
por: Wilson, Kirsty L., et al.
Publicado: (2016) -
Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes
por: Moody, Rhiane, et al.
Publicado: (2022)